![]() |
市場調查報告書
商品編碼
1451371
2024-2032 年按技術、應用(慢性阻塞性肺病、氣喘、呼吸窘迫症候群、睡眠呼吸中止症等)、最終用戶和地區分類的攜帶式製氧機市場報告Portable Oxygen Concentrators Market Report by Technology, Application (Chronic Obstructive Pulmonary Disease, Asthma, Respiratory Distress Syndrome, Sleep Apnea, and Others), End User, and Region 2024-2032 |
2023年,全球攜帶式製氧機市場規模達到18億美元。展望未來, IMARC Group預計到2032年市場規模將達到34億美元,2024-2032年複合年成長率(CAGR)為7.3%。慢性阻塞性肺病、氣喘和囊性纖維化等呼吸系統疾病發病率的上升、對家庭醫療護理的日益偏好以及老年人口的增加是推動市場的一些主要因素。
攜帶式製氧機 (POC) 是為患有呼吸系統疾病的人提供集中氧氣供應的醫療設備。它們旨在隨時隨地提供氧氣治療,使患者能夠保持積極的生活方式,並在傳統醫療環境之外獲得必要的氧氣支持。與依賴氧氣瓶或固定式濃縮器的傳統氧療方法不同,這些濃縮器結構緊湊、重量輕且易於運輸。它們的工作原理是吸入周圍空氣,過濾掉氮氣和其他氣體,並向使用者提供更高濃度的氧氣。
該市場主要是由二氧化碳(CO2)排放造成的環境污染不斷增加所推動的。此外,在氧氣水平不足的地方,旅行者和登山者對 POC 的需求不斷增加,這是另一個主要的成長誘導因素。此外,技術進步對市場的成長做出了巨大貢獻。製造商不斷創新,開發輕巧、緊湊和方便用戶使用的設備,為患者提供增強的攜帶性和便利性,這也促進了市場的成長。此外,全球醫療保健基礎設施支出的不斷成長也推動了市場的成長。此外,由於移動方便,患有睡眠呼吸中止症的患者對攜帶式製氧機的需求不斷成長,這在全球範圍內創造了良好的市場前景。
呼吸道疾病發生率上升
越來越多的人被診斷出患有肺癌、慢性阻塞性肺病、氣喘、肺纖維化和流感等呼吸系統疾病,因此需要有效的氧氣治療解決方案。 POC 提供了一種攜帶式且方便的選擇,用於向患者輸送氧氣,使他們能夠管理自己的病情並提高生活品質。呼吸系統疾病發生率的上升直接導致市場對POC的需求增加。此外,POC 使醫療保健提供者能夠將護理擴展到醫院之外,促進家庭氧氣治療並減輕醫療機構的負擔。此外,與傳統氧氣治療方法相比,POC 是一種經濟高效的解決方案,因為它們無需頻繁補充鋼瓶或固定濃縮器維護。
人們越來越偏好家庭醫療服務
家庭醫療強調需要攜帶式醫療設備,使患者無需局限於醫院或診所即可接受治療。 POC 提供了一種方便、輕巧的解決方案,用於在家中進行氧氣治療,從而滿足了這項要求。因此,人們對居家照護的日益青睞導致對攜帶式製氧機的需求不斷增加。此外,居家醫療保健可以減少住院時間、再入院和急診就診次數,從而為醫療保健系統提供潛在的成本節約。 POC 使患者能夠在家中接受氧氣治療,從而最大限度地減少因呼吸系統疾病而住院的需要。醫療保健資源和成本效益的最佳化是將 POC 整合到家庭護理策略中的促進因素。
老年人口不斷增加
隨著個體年齡的成長,慢性阻塞性肺病 (COPD)、肺炎和其他肺部相關疾病等呼吸系統疾病的風險也會增加。這些情況通常需要長期氧氣治療來控制症狀並改善生活品質。因此,老年人口的增加直接導致呼吸系統疾病盛行率的增加,從而導致對作為氧氣治療基本醫療設備的 POC 的需求增加。此外,POC 為老年人提供必要的移動性和攜帶性,使其能夠繼續積極的生活方式,同時獲得所需的氧氣支持。老年人口對積極老化的渴望推動了對 POC 的需求,使他們能夠充分參與他們想要的活動。
The global portable oxygen concentrators market size reached US$ 1.8 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 3.4 Billion by 2032, exhibiting a growth rate (CAGR) of 7.3% during 2024-2032. The rising incidences of respiratory diseases such as chronic obstructive pulmonary disease, asthma, and cystic fibrosis, the growing preference for home-based medical care, and the increasing geriatric population are some of the major factors propelling the market.
Portable oxygen concentrators (POCs) are medical devices that provide a concentrated supply of oxygen to individuals with respiratory conditions. They are designed to deliver oxygen therapy on-the-go, allowing patients to maintain an active lifestyle and receive the necessary oxygen support outside of traditional healthcare settings. These concentrators are compact, lightweight, and easily transportable unlike traditional oxygen therapy methods that rely on oxygen cylinders or stationary concentrators. They operate by drawing in ambient air, filtering out nitrogen and other gases, and delivering a higher concentration of oxygen to the user.
The market is primarily driven by the increasing amount of environmental pollution due to carbon dioxide (CO2) emissions. In addition, the escalating demand for POCs by travelers and mountaineers in places wherein the oxygen level is inadequate represents another major growth-inducing factor. Besides, technological advancements have significantly contributed to the growth of the market. Manufacturers are continuously innovating to develop lightweight, compact, and user-friendly devices that offer enhanced portability and convenience for patients, which is also augmenting the market growth. Moreover, the growing expenditure on healthcare infrastructure across the globe is also propelling the market growth. Furthermore, the rising demand for portable oxygen concentrators for the patients suffering from sleep apnea due to its easy of mobility, is creating a favorable market outlook across the globe.
The rising incidences of respiratory diseases
The growing number of individuals diagnosed with respiratory diseases such as lung cancer, COPD, asthma, pulmonary fibrosis, and flu, necessitates the availability of effective oxygen therapy solutions. POCs offer a portable and convenient option for delivering oxygen to patients, enabling them to manage their conditions and improve their quality of life. The rising incidences of respiratory diseases are directly contributing to the increased demand for POCs in the market. Moreover, POCs enable healthcare providers to extend care beyond the hospital walls, facilitating home-based oxygen therapy and reducing the burden on healthcare facilities. Additionally, POCs can be a cost-effective solution compared to traditional oxygen therapy methods, as they eliminate the need for frequent cylinder refills or stationary concentrator maintenance.
The growing preference for home-based medical care
Home-based medical care emphasizes the need for portable medical devices that enable patients to receive treatment without being confined to a hospital or clinic. POCs align with this requirement by providing a convenient and lightweight solution for delivering oxygen therapy at home. As a result, the growing preference for home-based care is escalating the demand for portable oxygen concentrators. Moreover, home-based medical care offers potential cost savings for healthcare systems by reducing hospital stays, readmissions, and emergency department visits. POCs enable patients to receive oxygen therapy at home, minimizing the need for hospital admissions related to respiratory conditions. This optimization of healthcare resources and cost-effectiveness is a driving factor in the integration of POCs into home-based care strategies.
The increasing geriatric population
As individuals age, the risk of developing respiratory conditions such as chronic obstructive pulmonary disease (COPD), pneumonia, and other lung-related ailments increases. These conditions often require long-term oxygen therapy to manage symptoms and improve the quality of life. Consequently, the rising geriatric population directly contributes to the increased prevalence of respiratory diseases, leading to a higher demand for POCs as an essential medical device for oxygen therapy. Moreover, POCs offer the necessary mobility and portability for the elderly population to continue their active lifestyle while receiving the oxygen support they require. The desire for active aging among the geriatric population drives the demand for POCs that enable them to participate fully in their desired activities.
IMARC Group provides an analysis of the key trends in each segment of the global portable oxygen concentrators market report, along with forecasts at the global, regional, and country levels from 2024-2032. Our report has categorized the market based on technology, application, and end user.
Continuous Flow
Pulse Flow
Pulse flow presently dominates the market
The report has provided a detailed breakup and analysis of the market based on technology. This includes continuous flow and pulse flow. According to the report, pulse flow represented the largest segment.
Pulse flow POCs operate by delivering oxygen in a pulsed or intermittent fashion, synchronized with the patient's inhalation. This intermittent delivery method allows for significant battery savings compared to continuous flow POCs. By delivering oxygen only when the patient breathes in, pulse flow POCs conserve energy, resulting in extended battery life. This feature is highly valued by users as it provides them with greater mobility and independence, allowing them to use the POC for longer durations without the need for frequent recharging or battery replacements. Moreover, these POCs are typically smaller, lighter, and more compact compared to continuous flow devices. This compact design enhances portability and ease of use, enabling users to carry the POC with them wherever they go. The lightweight nature and smaller size of pulse flow POCs contribute to their popularity among individuals who require oxygen therapy while maintaining an active lifestyle or traveling.
Chronic Obstructive Pulmonary Disease (COPD)
Asthma
Respiratory Distress Syndrome
Sleep Apnea
Others
Chronic obstructive pulmonary disease (COPD) represents the leading segment
A detailed breakup and analysis of the market based on the application has also been provided in the report. This includes chronic obstructive pulmonary disease (COPD), asthma, respiratory distress syndrome, sleep apnea, and others. According to the report, chronic obstructive pulmonary disease (COPD) represented the largest segment.
COPD is a prevalent respiratory disease globally, with a significant number of individuals diagnosed with the condition. The high prevalence of COPD directly translates to a larger patient base in need of oxygen therapy, driving the demand for POCs. Oxygen therapy plays a crucial role in managing COPD and improving patients' quality of life as many individuals with COPD require long-term oxygen therapy to maintain adequate oxygen levels and alleviate symptoms such as shortness of breath. Besides, the POC market has witnessed significant technological advancements, improving the performance, efficiency, and convenience of POCs for COPD patients. Advanced sensors, algorithms, and control systems in POCs enable precise oxygen delivery, synchronization with the patient's breath, and extended battery life. These technological advancements enhance the user experience, making POCs more user-friendly and reliable for COPD patients.
Hospitals
Ambulatory Surgery Centers
Others
Ambulatory surgery centers hold the largest share in the market
A detailed breakup and analysis of the market based on the end user has also been provided in the report. This includes hospitals, ambulatory surgery centers, and others. According to the report, ambulatory surgery centers represented the largest segment.
ASCs have witnessed significant growth and popularity in recent years due to various advantages they offer. ASCs provide a cost-effective alternative to inpatient hospital stays, allowing patients to undergo surgical procedures in a more efficient and comfortable setting. The increasing number of ASCs globally directly contributes to the larger customer base and demand for POCs in these facilities. Moreover, many surgical procedures performed in ASCs require the administration of supplemental oxygen to ensure patient safety and comfort. POCs are the preferred choice for oxygen therapy in ASCs due to their portability, ease of use, and convenience. The compact size and mobility of POCs make them well-suited for use in outpatient settings, enabling patients to receive oxygen therapy while moving around the facility.
North America
United States
Canada
Asia Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
North America exhibits a clear dominance, accounting for the largest portable oxygen concentrators market share
The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America was the largest market.
North America has a significant prevalence of respiratory diseases, such as chronic obstructive pulmonary disease (COPD), asthma, and other lung-related ailments. The region's aging population, environmental factors, and lifestyle choices contribute to the higher occurrence of respiratory conditions. The greater prevalence of these diseases creates a larger patient base in need of oxygen therapy, driving the demand for POCs in North America. Moreover, the region boasts a well-developed healthcare infrastructure, characterized by advanced medical facilities, a robust healthcare system, and significant investments in healthcare research and development. The presence of advanced hospitals, clinics, and ambulatory surgery centers creates a conducive environment for the adoption of POCs. Besides, the POC market has witnessed continuous technological advancements, and North America has been at the forefront of these innovations. The region is home to several key players in the healthcare and medical device industry, fostering a culture of research and development.
The competitive landscape of the market is characterized by the presence of several key players competing to gain market share. These companies strive to develop innovative products, expand their distribution networks, and provide comprehensive after-sales support. Nowadays, the leading players are investing in research and development (R&D) activities to develop advanced product variants. They are also designing a diverse range of POC models designed for both home and travel use. Moreover, various key players are engaging in collaborations and mergers and acquisitions (M&As) to strengthen their market foothold and gain a competitive edge in the market.
Caire Inc. (NGK Spark Plug Co. Ltd)
Chart Industries Inc.
Drive Devilbiss Healthcare Limited (Drive International LLC)
Inogen Inc.
Invacare Corporation
Koninklijke Philips N.V
Nidek Medical India Pvt Ltd
O2 Concepts LLC
Precision Medical Inc. (BioHorizons Inc.)
Resmed Inc.
Teijin Limited
Philips Respironics, a subsidiary of Philips company, is introducing a range of POCs with advanced features such as extended battery life, user-friendly interfaces, and connectivity options.
Inogen Inc., a leading manufacturer of POCs specializing in lightweight and portable devices, is focusing on direct-to-consumer sales and providing excellent customer service to strengthen its market foothold.
ResMed Inc., a leading provider of medical devices and solutions for sleep apnea and respiratory disorders, has expanded its portfolio to include POCs that offer advanced features, comfort, and efficient oxygen delivery. The company is also integrating technology and data connectivity to enhance patient monitoring and therapy management.